17093087|t|Broad-spectrum effects of 4-aminopyridine to modulate amyloid beta1-42-induced cell signaling and functional responses in human microglia.
17093087|a|We investigated the modulating actions of the nonselective K(+) channel blocker 4-aminopyridine (4-AP) on amyloid beta (Abeta(1-42))-induced human microglial signaling pathways and functional processes. Whole-cell patch-clamp studies showed acute application of Abeta(1-42) (5 mum) to human microglia led to rapid expression of a 4-AP-sensitive, non-inactivating outwardly rectifying K(+) current (I(K)). Intracellular application of the nonhydrolyzable analog of GTP, GTPgammaS, induced an outward K(+) current with similar properties to the Abeta(1-42)-induced I(K) including sensitivity to 4-AP (IC(50) = 5 mm). Reverse transcriptase-PCR showed a rapid expression of a delayed rectifier Kv3.1 channel in Abeta(1-42)-treated microglia. Abeta(1-42) peptide also caused a slow, progressive increase in levels of [Ca(2+)](i) (intracellular calcium) that was partially blocked by 4-AP. Chronic exposure of human microglia to Abeta(1-42) led to enhanced p38 mitogen-activated protein kinase and nuclear factor kappaB expression with factors inhibited by 4-AP. Abeta(1-42) also induced the expression and production of the pro-inflammatory cytokines interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha, the chemokine IL-8, and the enzyme cyclooxygenase-2; 4-AP was effective in reducing all of these pro-inflammatory mediators. Additionally, toxicity of supernatant from Abeta(1-42)-treated microglia on cultured rat hippocampal neurons was reduced if 4-AP was included with peptide. In vivo, injection of Abeta(1-42) into rat hippocampus induced neuronal damage and increased microglial activation. Daily administration of 1 mg/kg 4-AP was found to suppress microglial activation and exhibited neuroprotection. The overall results suggest that 4-AP modulation of an Abeta(1-42)-induced I(K) (candidate channel Kv3.1) and intracellular signaling pathways in human microglia could serve as a therapeutic strategy for neuroprotection in Alzheimer's disease pathology.
17093087	26	41	4-aminopyridine	Chemical	MESH:D015761
17093087	122	127	human	Species	9606
17093087	219	234	4-aminopyridine	Chemical	MESH:D015761
17093087	236	240	4-AP	Chemical	MESH:D015761
17093087	245	257	amyloid beta	Gene	351
17093087	280	285	human	Species	9606
17093087	424	429	human	Species	9606
17093087	469	473	4-AP	Chemical	MESH:D015761
17093087	603	606	GTP	Chemical	MESH:D006160
17093087	608	617	GTPgammaS	Chemical	MESH:D016244
17093087	732	736	4-AP	Chemical	MESH:D015761
17093087	829	834	Kv3.1	Gene	3746
17093087	952	958	Ca(2+)	Chemical	-
17093087	978	985	calcium	Chemical	MESH:D002118
17093087	1017	1021	4-AP	Chemical	MESH:D015761
17093087	1043	1048	human	Species	9606
17093087	1090	1126	p38 mitogen-activated protein kinase	Gene	1432
17093087	1190	1194	4-AP	Chemical	MESH:D015761
17093087	1262	1274	inflammatory	Disease	MESH:D007249
17093087	1285	1307	interleukin (IL)-1beta	Gene	3553
17093087	1309	1313	IL-6	Gene	3569
17093087	1319	1346	tumor necrosis factor-alpha	Gene	7124
17093087	1362	1366	IL-8	Gene	3576
17093087	1383	1399	cyclooxygenase-2	Gene	5743
17093087	1401	1405	4-AP	Chemical	MESH:D015761
17093087	1449	1461	inflammatory	Disease	MESH:D007249
17093087	1487	1495	toxicity	Disease	MESH:D064420
17093087	1558	1561	rat	Species	10116
17093087	1597	1601	4-AP	Chemical	MESH:D015761
17093087	1668	1671	rat	Species	10116
17093087	1692	1707	neuronal damage	Disease	MESH:D009410
17093087	1777	1781	4-AP	Chemical	MESH:D015761
17093087	1890	1894	4-AP	Chemical	MESH:D015761
17093087	1956	1961	Kv3.1	Gene	3746
17093087	2003	2008	human	Species	9606
17093087	2080	2099	Alzheimer's disease	Disease	MESH:D000544
17093087	Negative_Correlation	MESH:D015761	MESH:D064420
17093087	Association	MESH:D007249	7124
17093087	Negative_Correlation	MESH:D015761	MESH:D007249
17093087	Negative_Correlation	MESH:D015761	5743
17093087	Negative_Correlation	MESH:D015761	1432
17093087	Association	MESH:D007249	5743
17093087	Association	MESH:D007249	3569
17093087	Negative_Correlation	MESH:D015761	7124
17093087	Negative_Correlation	MESH:D015761	3553
17093087	Negative_Correlation	MESH:D002118	MESH:D015761
17093087	Negative_Correlation	MESH:D015761	3576
17093087	Negative_Correlation	MESH:D015761	3569

